Abstract
Nonsense-mediated mRNA decay (NMD) functions to ensure quality gene expression by degrading mRNAs that prematurely terminate translation. By so doing, it eliminates the production of potentially deleterious truncated proteins. NMD also degrades certain naturally occurring transcripts as a means of achieving proper levels of gene expression. With the exception of prokaryotes, NMD typifies all organisms that have been examined. As an example of its importance, NMD is required for the viability of mammalian blastocysts in culture as well as mammalian embryos in utero. The repertoire of factors that mediate NMD is larger in C. elegans, D. melanogaster, mammalian cells and, possibly, A. thaliana, than it is in S. cerevisiae and S. pombe. NMD requires not only a premature termination codon but also a downstream element. Whereas this element in S. cerevisiae, S. pombe, C. elegans, D. melanogaster and plants is debatably either a short cis-acting mRNA sequence or an abnormal 3 untranslated region, it is a splicing-generated exon junction complex of proteins in mammalian cells. In fact, NMD may have provided a selective pressure for where introns colonize within mammalian genes. There also appear to be differences among different eukaryotes as to whether NMD is restricted to newly synthesized mRNA or can also target steady-state mRNA. In summary, despite the conservation of NMD in eukaryotes, different mechanisms have evolved to define those premature termination codons that elicit NMD.
Keywords: nonsense-mediated mrna decay, rna surveillance, premature termination of translation, upf proteins
Current Genomics
Title: Nonsense-Mediated mRNA Decay: A Comparative Analysis of Different Species
Volume: 5 Issue: 3
Author(s): L. E. Maquat
Affiliation:
Keywords: nonsense-mediated mrna decay, rna surveillance, premature termination of translation, upf proteins
Abstract: Nonsense-mediated mRNA decay (NMD) functions to ensure quality gene expression by degrading mRNAs that prematurely terminate translation. By so doing, it eliminates the production of potentially deleterious truncated proteins. NMD also degrades certain naturally occurring transcripts as a means of achieving proper levels of gene expression. With the exception of prokaryotes, NMD typifies all organisms that have been examined. As an example of its importance, NMD is required for the viability of mammalian blastocysts in culture as well as mammalian embryos in utero. The repertoire of factors that mediate NMD is larger in C. elegans, D. melanogaster, mammalian cells and, possibly, A. thaliana, than it is in S. cerevisiae and S. pombe. NMD requires not only a premature termination codon but also a downstream element. Whereas this element in S. cerevisiae, S. pombe, C. elegans, D. melanogaster and plants is debatably either a short cis-acting mRNA sequence or an abnormal 3 untranslated region, it is a splicing-generated exon junction complex of proteins in mammalian cells. In fact, NMD may have provided a selective pressure for where introns colonize within mammalian genes. There also appear to be differences among different eukaryotes as to whether NMD is restricted to newly synthesized mRNA or can also target steady-state mRNA. In summary, despite the conservation of NMD in eukaryotes, different mechanisms have evolved to define those premature termination codons that elicit NMD.
Export Options
About this article
Cite this article as:
Maquat E. L., Nonsense-Mediated mRNA Decay: A Comparative Analysis of Different Species, Current Genomics 2004; 5 (3) . https://dx.doi.org/10.2174/1389202043349453
DOI https://dx.doi.org/10.2174/1389202043349453 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Tyrosine Kinase Mutations in Human Cancer
Current Molecular Medicine Polyphenols Beyond Barriers: A Glimpse into the Brain
Current Neuropharmacology Combinatorial Carbohydrate Synthesis
Mini-Reviews in Organic Chemistry Detection and Specific Targeting of Hypoxic Regions within Solid Tumors: Current Preclinical and Clinical Strategies
Current Medicinal Chemistry Cancer and Cyclooxygenase-2 (COX-2) Inhibition
Current Pharmaceutical Design Targeting Matrix Metalloproteinases in Inflammatory Conditions
Current Drug Targets Targeted Cancer Therapy; Nanotechnology Approaches for Overcoming Drug Resistance
Current Medicinal Chemistry BCR-ABL Inhibitors in Chronic Myeloid Leukemia: Process Chemistry and Biochemical Profile
Current Medicinal Chemistry Chemokines and Defensins as HIV Suppressive Factors: An Evolving Story
Current Pharmaceutical Design Epigenetics: Relations to Disease and Laboratory Findings
Current Medicinal Chemistry Notch-Associated MicroRNAs in Cancer
Current Drug Targets New Molecules and Strategies in the Field of Anticancer Agents
Current Medicinal Chemistry - Anti-Cancer Agents Radioprotective Gene Therapy
Current Gene Therapy In Vivo Biological Evaluation of Ethyl 4-(7-hydroxy-4-methyl-2-oxoquinolin-1- ylamino)-coumarin-3-carboxylate as an Antitumor Agent
Anti-Cancer Agents in Medicinal Chemistry Sinonasal Carcinoma: Updated Phenotypic and Molecular Characterization
Current Cancer Therapy Reviews Interleukin 10 in Antiviral Responses
Current Immunology Reviews (Discontinued) The Therapeutic Potential of Stem Cells in Amyotrophic Lateral Sclerosis
Current Signal Transduction Therapy Computational Evaluation and In Vitro Validation of New Epidermal Growth Factor Receptor Inhibitors
Current Topics in Medicinal Chemistry The Role of Tumor Suppressor Dysregulation in Prostate Cancer Progression
Current Drug Targets Transition Metal Based Anticancer Drugs
Current Topics in Medicinal Chemistry